0002032849-26-000001.txt : 20260209 0002032849-26-000001.hdr.sgml : 20260209 20260209150720 ACCESSION NUMBER: 0002032849-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260209 DATE AS OF CHANGE: 20260209 EFFECTIVENESS DATE: 20260209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ensho Therapeutics, Inc. CENTRAL INDEX KEY: 0002032849 ORGANIZATION NAME: EIN: 992570254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-572987 FILM NUMBER: 26611102 BUSINESS ADDRESS: STREET 1: 422 MOUNTAIN WAY CITY: MORRIS PLAINS STATE: NY ZIP: 07950 BUSINESS PHONE: 973-241-3669 MAIL ADDRESS: STREET 1: 422 MOUNTAIN WAY CITY: MORRIS PLAINS STATE: NY ZIP: 07950 D 1 primary_doc.xml X0708 D LIVE 0002032849 Ensho Therapeutics, Inc. 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 973-475-8970 DELAWARE None None Corporation true 2024 Danielle Fry 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Executive Officer Arash Rassoulpour 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Director Carlos Solorzano 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Director Eric Pham 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Director Gerhard Hagn 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Executive Officer Biotechnology Decline to Disclose 06b false 2026-01-20 false true true false 1 20000000 0 20000000 false 9 0 0 0 false Ensho Therapeutics, Inc. /s/ Danielle Fry Danielle Fry Chief Legal Officer & Chief Operating Officer 2026-02-09